Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

被引：0
|
作者：
Yue-qin Wang
Ai-jun Shen
Jing-ya Sun
Xin Wang
Hong-chun Liu
Min-min Zhang
Dan-qi Chen
Bing Xiong
Jing-kang Shen
Mei-yu Geng
Min Zheng
Jian Ding
机构：
[1] China Pharmaceutical University,Department of New Drug Screening Center
[2] Division of Anti-tumor Pharmacology,Department of Thoracic Surgery
[3] Synthetic Organic and Medicinal Chemistry Laboratory,undefined
[4] State Key Laboratory of Drug Research,undefined
[5] Shanghai Institute of Materia Medica,undefined
[6] Chinese Academy of Sciences,undefined
[7] Shanghai Tongren Hospital,undefined
[8] Shanghai Jiao Tong University School of Medicine,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
non-small cell lung cancer; gefitinib resistance; Hsp90;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1587 / 1596
页数：9
相关论文
共 50 条
  • [31] Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells
    Takenaka, Tomoya
    Nakai, Shinya
    Katayama, Miku
    Hirano, Mami
    Ueno, Natsumi
    Noguchi, Kosuke
    Takatani-Nakase, Tomoka
    Fujii, Ikuo
    Kobayashi, Susumu S.
    Nakase, Ikuhiko
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 572
  • [32] Targeting slow-cycling persisters in EGFR mutant non-small cell lung cancer
    Thiruvalluvan, Manish
    Billet, Sandrine
    Liu, Zhenqiu
    Lownik, Joseph
    Gonzales, Gabrielle
    Kim, Hyoyoung
    Villamejor, Anton L.
    Milshteyn, Larry
    Sankar, Kamya
    Posadas, Edwin M.
    Lopategui, Jean
    You, Sungyong
    Reckamp, Karen
    Bhowmick, Neil A.
    CANCER RESEARCH, 2024, 84 (06)
  • [33] β-Catenin overexpression is associated with gefitinib resistance in non-small cell lung cancer cells
    Fang, Xia
    Gu, Pan
    Zhou, Caicun
    Liang, Aibin
    Ren, Shenxiang
    Liu, Fang
    Zeng, Yu
    Wu, Yunjin
    Zhao, Yinmin
    Huang, Binbin
    Zhang, Zongmei
    Yi, Xianghua
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 28 (01) : 41 - 48
  • [34] Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
    David A. Proia
    Jim Sang
    Suqin He
    Donald L. Smith
    Manuel Sequeira
    Chaohua Zhang
    Yuan Liu
    Shuxia Ye
    Dan Zhou
    Ronald K. Blackman
    Kevin P. Foley
    Keizo Koya
    Yumiko Wada
    Investigational New Drugs, 2012, 30 : 2201 - 2209
  • [35] Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
    Proia, David A.
    Sang, Jim
    He, Suqin
    Smith, Donald L.
    Sequeira, Manuel
    Zhang, Chaohua
    Liu, Yuan
    Ye, Shuxia
    Zhou, Dan
    Blackman, Ronald K.
    Foley, Kevin P.
    Koya, Keizo
    Wada, Yumiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2201 - 2209
  • [36] Prognostic value of the mRNA expression of members of the HSP90 family in non-small cell lung cancer
    Liu, Kang
    Kang, Min
    Li, Jixi
    Qin, Wen
    Wang, Rensheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (04) : 2657 - 2665
  • [37] Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
    Kim, Youjin
    Lee, Se-Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 502 - 509
  • [38] Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells
    Zhang, Dianbao
    Yang, Yukun
    Kang, Yixin
    Xie, Dongjie
    Zhang, Xianfen
    Hao, Jiqing
    JOURNAL OF THORACIC DISEASE, 2023, 15 (04) : 1978 - 1993
  • [39] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [40] Hsp90 inhibitors enhance the antitumoral effect of osimertinib and overcome osimertinib resistance in non-small cell cell lung cancer cell models
    Codony-Servat, J.
    Codony-Servat, C.
    Viteri, S.
    Ito, M.
    Chaib, I.
    Bracht, J.
    Molina-Vila, M. A.
    Karachaliou, N.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2019, 30
12345